Paul Chidsey, Brigham Young University
Chemistry and Biochemistry
It has been reported that an estimated 11% of women in the population have undiagnosed endometriosis, emphasizing the need for early detection tests and treatment options. Diagnosis is typically determined through an analysis of symptoms, including painful menstrual cycles, pain in the lower abdomen, and prolonged menstrual cramping. Diagnosis is further confirmed through invasive procedures such as transvaginal ultrasound and pelvic laparoscopy. Serum proteomic studies in which small biomolecules and peptides are analyzed for biological significance in endometriosis cases and controls can lead to the discovery of novel methods whereby the disease is detected and eventually treated earlier in development without the need of invasive procedures. Comparative analysis of cases and controls through mass spectroscopy has led to the discovery of novel biomarkers capable of correctly identifying individuals with endometriosis. Further pursuing this study will allow for a greater understanding of the genesis of the disease, eventually uncovering the mechanism whereby endometriosis develops.